Editorial Board About Us

Watchful waiting

All articles from this key word are listed below.

Volume 6, Number 4 Review Articles

Preventing Progression in Men With Mild Symptoms of Benign Prostatic Hyperplasia: A Potential Role for Phytotherapy

Treatment Review

Yan Kit Fong Sibylle Marihart Mike Harik Bob Djavan

Benign prostatic hyperplasia Watchful waiting Progression Phytotherapy

Volume 10, Number 3 Review Articles

Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice

Diagnostic Update

Leonard S Marks David G Bostwick

A specific marker for early prostate cancer would fill an important void. In initial evaluations of the prostate cancer antigen 3 (PCA3) gene vis-à-vis serum prostate-specific antigen (PSA) levels, the gene offers great promise. At the cellular level, PCA3 specificity for cancer is nearly perfect because of the gross overexpression of the gene by cancer cells. As a clinical test for early prostate cancer, heightened specificity is also seen in urine containing prostate cells from men with the disease. PCA3 gene testing holds valuable potential in PSA quandary situations: (1) men with elevated PSA levels but no cancer on initial biopsy; (2) men found to have cancer despite normal levels of PSA; (3) men with PSA elevations associated with varying degrees of prostatitis; and (4) men undergoing active surveillance for presumed microfocal disease. [Rev Urol. 2008;10(3):175-181]

Prostate cancer Benign prostatic hyperplasia Prostate-specific antigen Prostatitis Watchful waiting Prostate cancer antigen 3 gene Microfocal disease

Volume 11, Number 2 Meeting Reviews

Best of the 2009 AUA Annual Meeting

Highlights From the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL

Naoki Yoshimura F Pouliot B Shuch Arie S Belldegrun Dean G Assimos Michael K Brawer Claus G Roehrborn J Curtis Nickel Stacy Loeb Michael B Chancellor Alan W Partin Ellen Shapiro

Prostate cancer screening Obesity Benign prostatic hyperplasia Lower urinary tract symptoms Vesicoureteral reflux Nephrolithiasis Stress urinary incontinence Inflammation Silodosin Hormonal therapy Tumor markers TMPRSS2ERG 4-Kallikrein panel Botulinum toxin type A Male voiding dysfunction Benign prostatic specific antigen Roux-en-Y gastric bypass surgery Genitourinary pain index UPOINT clinical phenotype system Nephron-sparing surgery Watchful waiting Laparoscopy for adrenal cortical carcinoma Partial adrenalectomy Urethral trauma Pediatric urethral stricture Enteric urologic surgery